Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1992-02-21
1993-06-29
Reamer, James H.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424 2, 424 9, 424486, 424400, A61K 4300
Patent
active
052232425
ABSTRACT:
An in vivo imaging or therapeutic method including administering to a mammal a specific affinity reagent including a physiologically compatible polymer bonded to one or more specific affinity molecules capable of selectively binding to a predetermined substance or class of cells, and one or more reporter groups capable of providing detectable contrast between the predetermined substance or class of cells and cells or substances of the mammal to which the specific affinity reagent does not bind, or of killing cells of the predetermined class.
REFERENCES:
patent: 4046722 (1977-09-01), Rowland
patent: 4731239 (1988-03-01), Gordon
Khaw Ban A.
Klibanov Alexander L.
Torchilin Vladimir
Reamer James H.
The General Hospital Corporation
USSR Cardiology Research Centre
LandOfFree
Negatively charged specific affinity reagents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Negatively charged specific affinity reagents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Negatively charged specific affinity reagents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1753613